Lymphangioleiomyomatosis: what do we know and what are we looking for?

Lymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects predominantly females and can occur sporadically or in pat...

Full description

Bibliographic Details
Main Authors: O. Torre, S. Harari, J. Moss
Format: Article
Language:English
Published: European Respiratory Society 2011-03-01
Series:European Respiratory Review
Subjects:
Online Access:http://err.ersjournals.com/content/20/119/034.full.pdf+html
_version_ 1818236424793620480
author O. Torre
S. Harari
J. Moss
author_facet O. Torre
S. Harari
J. Moss
author_sort O. Torre
collection DOAJ
description Lymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects predominantly females and can occur sporadically or in patients with tuberous sclerosis complex. This review describes the recent progress in our understanding of the molecular pathogenesis of the disease and LAM cell biology. It also summarises current therapeutic approaches and the most promising areas of research for future therapeutic strategies.
first_indexed 2024-12-12T12:09:39Z
format Article
id doaj.art-3a5d6428fd6c492e8688927fe694a8d2
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-12T12:09:39Z
publishDate 2011-03-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-3a5d6428fd6c492e8688927fe694a8d22022-12-22T00:24:56ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172011-03-01201193444Lymphangioleiomyomatosis: what do we know and what are we looking for?O. TorreS. HarariJ. MossLymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects predominantly females and can occur sporadically or in patients with tuberous sclerosis complex. This review describes the recent progress in our understanding of the molecular pathogenesis of the disease and LAM cell biology. It also summarises current therapeutic approaches and the most promising areas of research for future therapeutic strategies.http://err.ersjournals.com/content/20/119/034.full.pdf+htmlLAM cellslymphangioleiomyomatosistuberous sclerosis complex
spellingShingle O. Torre
S. Harari
J. Moss
Lymphangioleiomyomatosis: what do we know and what are we looking for?
European Respiratory Review
LAM cells
lymphangioleiomyomatosis
tuberous sclerosis complex
title Lymphangioleiomyomatosis: what do we know and what are we looking for?
title_full Lymphangioleiomyomatosis: what do we know and what are we looking for?
title_fullStr Lymphangioleiomyomatosis: what do we know and what are we looking for?
title_full_unstemmed Lymphangioleiomyomatosis: what do we know and what are we looking for?
title_short Lymphangioleiomyomatosis: what do we know and what are we looking for?
title_sort lymphangioleiomyomatosis what do we know and what are we looking for
topic LAM cells
lymphangioleiomyomatosis
tuberous sclerosis complex
url http://err.ersjournals.com/content/20/119/034.full.pdf+html
work_keys_str_mv AT otorre lymphangioleiomyomatosiswhatdoweknowandwhatarewelookingfor
AT sharari lymphangioleiomyomatosiswhatdoweknowandwhatarewelookingfor
AT jmoss lymphangioleiomyomatosiswhatdoweknowandwhatarewelookingfor